Ohcanbohtosat - Gordon, Stuart C
- Čájehuvvo 1 - 20 / 63
- Sirdás čuovvovaš siidui
-
1
Utility of IL-28B Polymorphisms in the Era of Direct-Acting Antiviral Therapy Dahkki Gordon, Stuart C.
Almmustuhtton 2011Teaksta -
2
Polycystic Liver Disease Dahkki Gordon, Stuart C.
Almmustuhtton 2015Teaksta -
3
Hepatitis C Virus Detection and Treatment in Rural Communities Dahkki Gordon, Stuart C.
Almmustuhtton 2018Teaksta -
4
Update on Polycystic Liver Disease Dahkki Gordon, Stuart C.
Almmustuhtton 2020Teaksta -
5
Epidemiology of Hepatitis C Dahkki Jafri, Syed‐Mohammed, Gordon, Stuart C.
Almmustuhtton 2018Teaksta -
6
-
7
Management of Direct‐Acting Antiviral Failures Dahkki Alimirah, Maryam, Sadiq, Omar, Gordon, Stuart C.
Almmustuhtton 2020Teaksta -
8
Response to: ‘No impact of Covid‐19 pandemic on decompensation of alcoholic liver disease: Results from a single Center in Milan’ Dahkki Gonzalez, Humberto C., Rupp, Loralee B., Trudeau, Sheri, Gordon, Stuart C.
Almmustuhtton 2022Teaksta -
9
-
10
Assessment of cost of innovation versus the value of health gains associated with treatment of chronic hepatitis C in the United States: The quality-adjusted cost of care Dahkki Younossi, Zobair M., Park, Haesuk, Dieterich, Douglas, Saab, Sammy, Ahmed, Aijaz, Gordon, Stuart C.
Almmustuhtton 2016Teaksta -
11
Health Care Use and Costs Among Patients With Nonalcoholic Steatohepatitis With Advanced Fibrosis Using the Fibrosis‐4 Score Dahkki Gordon, Stuart C., Kachru, Nandita, Parker, Emily, Korrer, Stephanie, Ozbay, A. Burak, Wong, Robert J.
Almmustuhtton 2020Teaksta -
12
Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records Dahkki Lu, Mei, Chacra, Wadih, Rabin, David, Rupp, Loralee B, Trudeau, Sheri, Li, Jia, Gordon, Stuart C
Almmustuhtton 2017Teaksta -
13
-
14
Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases Dahkki Wong, Robert J., Kachru, Nandita, Martinez, Diane J., Moynihan, Meghan, Ozbay, A. Burak, Gordon, Stuart C.
Almmustuhtton 2021Teaksta -
15
Hepatitis B e Antigen Status and Hepatitis B DNA Levels in Women of Childbearing Age with Chronic Hepatitis B Infection Screening for Clinical Trials Dahkki Tran, Tram T., Gordon, Stuart C., Fung, Scott, Dinh, Phillip, Yee, Leland, Martins, Eduardo Bruno, Buti, Maria, Marcellin, Patrick
Almmustuhtton 2015Teaksta -
16
-
17
Differences in Hepatic Phenotype Between Hemochromatosis Patients with HFE C282Y Homozygosity and Other HFE Genotypes Dahkki Cheng, Raymond, Barton, James C., Morrison, Elizabeth D., Phatak, Pradyumna D., Krawitt, Edward L., Gordon, Stuart C., Kowdley, Kris V.
Almmustuhtton 2009Teaksta -
18
Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B Dahkki Nguyen, Mindie H., Lim, Joseph K., Burak Ozbay, A., Fraysse, Jeremy, Liou, Iris, Meyer, Nicole, Dusheiko, Geoffrey, Gordon, Stuart C.
Almmustuhtton 2019Teaksta -
19
Incidence of Cancer and Cancer-related Mortality Among Persons with Chronic Hepatitis C Infection, 2006–2010 Dahkki Allison, Robert D., Tong, Xin, Moorman, Anne C., Ly, Kathleen N., Rupp, Loralee, Xu, Fujie, Gordon, Stuart C., Holmberg, Scott D.
Almmustuhtton 2015Teaksta -
20
Hepatitis C Retreatment in the Era of Direct-Acting Antivirals: Projections in the United States Dahkki Chhatwal, Jagpreet, Chen, Qiushi, Ayer, Turgay, Bethea, Emily D., Kanwal, Fasiha, Kowdley, Kris V., Wang, Xiaojie, Roberts, Mark S., Gordon, Stuart C.
Almmustuhtton 2018Teaksta